The Efficacy Of Intravitreal Bevacizumab For Macula Edema Of Central Retinal Vein Occlusion.

被引：0
|
作者：
Iwabuchi, Shigehiro [1 ]
Saito, Yuta [1 ]
Onda, Hidetoshi [1 ]
Takahashi, Haruo [1 ]
机构：
[1] Showa Univ, Sch Med, Dept Ophthalmol, Shinagawa Ku, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
585; macula/fovea; 505; edema; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4434
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intravitreal ranibizumab following bevacizumab for macular edema due to retinal vein occlusion
    Durieux, P.
    Labalette, P.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [22] Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
    Leangelo Hall
    Luma Paiva Frizzera
    Laura Fernandes Coelho
    Pedro Carlos Carricondo
    Maria Kiyoko Oyamada
    Sergio Luis Gianotti Pimentel
    Maria Fernanda Abalem
    International Journal of Retina and Vitreous, 5
  • [23] Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
    Hall, Leangelo
    Frizzera, Luma Paiva
    Coelho, Laura Fernandes
    Carricondo, Pedro Carlos
    Oyamada, Maria Kiyoko
    Pimentel, Sergio Luis Gianotti
    Abalem, Maria Fernanda
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2019, 5 (01) : 1 - 8
  • [24] Comparing the efficacy of bevacizumab to ranibizumab in patients with retinal vein occlusion. The BRVO study
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    de Jong-Hesse, Y.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Schlingemann, R. O.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 39 - 40
  • [25] Intravitreal bevacizumab for branch retinal vein occlusion
    Spandau, Ulrich
    Wickenhaeuser, Anne
    Rensch, Florian
    Jonas, Jost
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (01): : 118 - 119
  • [26] INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Risard, Sarah M.
    Pieramici, Dante J.
    Rabena, Melvin D.
    Basefsky, Jessica C.
    Avery, Robert L.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    See, Robert F.
    Couvillion, Stephen S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1060 - 1067
  • [27] Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
    Yoo, Seul Gi
    Kim, Jae Hui
    Lee, Tae Gon
    Kim, Chul Gu
    Kim, Jong Woo
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (01) : 25 - 29
  • [28] Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide
    Le Moigne, O.
    Duncombe, A.
    Portmann, A.
    Muraine, M.
    Genevois, O.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2012, 35 (09): : 700 - 704
  • [29] Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin®):: Preliminary results
    Pournaras, J. -A. C.
    Nguyen, C.
    Vaudaux, J. D.
    Konstantinidis, L.
    Ambresin, A.
    Wolfensberger, T.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (05) : 397 - 400
  • [30] PROSPECTIVE STUDY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Ding, Xiaoyan
    Li, Jiaqing
    Hu, Xuting
    Yu, Shanshan
    Pan, Jianying
    Tang, Shibo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 838 - 845
12345